Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05439200 · ClinicalTrials.gov registry record · NA

Video Treatment for Amblyopia

A NA study of Amblyopia, sponsored by Retina Foundation of the Southwest.

Recruiting
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT05439200 is a NA study of Amblyopia that is actively recruiting participants, run by Retina Foundation of the Southwest. The registered enrollment target is 44 participants, below the 164-participant average among 24 other Amblyopia trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05439200, a NA study of Amblyopia, is actively recruiting participants, sponsored by Retina Foundation of the Southwest.

RECRUITING
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether viewing asynchronous movies leads to better visual outcomes in young children with amblyopia than standard-of-care occlusion therapy with an adhesive patch and whether this is associated with better adherence to treatment.

Conditions Studied

Interventions

  • DEVICE Asynchronous 3D movies
  • DEVICE Patching

Study Locations (1)

Texas

  • Retina Foundation - Dallas

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2023-08-23
Est. Completion 2027-06-30
Phase NA

Sponsor

Retina Foundation of the Southwest

11 total trials

What the Registry Record Tells You About NCT05439200

The ClinicalTrials.gov registry entry for NCT05439200 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 164-participant average among 24 other Amblyopia trials with a reported enrollment target (73% lower). The listed sponsor is Retina Foundation of the Southwest, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 2 interventions - of which Asynchronous 3D movies is the first listed.

NCT05439200 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05439200 about?

NCT05439200 is a clinical study titled "Video Treatment for Amblyopia". The purpose of this study is to determine whether viewing asynchronous movies leads to better visual outcomes in young children with amblyopia than standard-of-care occlusion therapy with an adhesive patch and whether this is associated with better adherence to treatment.

What is the current status of trial NCT05439200?

This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2023-08-23. Estimated completion is 2027-06-30.

What conditions does trial NCT05439200 study?

This clinical trial studies the following conditions: Amblyopia.

What interventions are being tested in trial NCT05439200?

The interventions under investigation include: Asynchronous 3D movies (DEVICE), Patching (DEVICE).

Who is sponsoring clinical trial NCT05439200?

This trial is sponsored by Retina Foundation of the Southwest, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05439200 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amblyopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.